Intrastriatal transplantation of Sertoli cells may improve amphetamine- induced rotation and tyrosine hydroxylase immunoreactivity of the striatum in hemiparkinsonian rats

Brain Research

Volumn 838, Issue 1-2, 1999, Pages 227-233

  Liu, Hwan Wun ^a   Kuang, Ya Jane ^a   Wu, Jiahn Chun ^b   Ma, Kuo Hsing ^a   Wang, Shwun De ^a   Liu, Jiang Chuan ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Parkinson's disease; Sertoli cell; Striatum; Substantia nigra; Transplantation

Indexed keywords

AMPHETAMINE; CADHERIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE SIMULATION; IMMUNOREACTIVITY; MALE; NEUROTROPISM; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; ROTATION; SERTOLI CELL; STRIATE CORTEX; SUBSTANTIA NIGRA;

AMPHETAMINE; ANIMALS; CORPUS STRIATUM; IMMUNOHISTOCHEMISTRY; MALE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; SERTOLI CELLS; SWINE; TYROSINE 3-MONOOXYGENASE;

EID: 0033554227     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01656-X     Document Type: Article

References (26)

1. Bean A.J., Elde R., Cao Y., Oellig C., Tamminga C., Gold-stein M., Pettersson P.F., Hokfelt T. Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10237-10241.
2. Bellgrau D., Gold D., Selawry H., Moore J., Franzusof A., Duke R.C. A role for CD95 ligand in preventing graft rejection. Nature. 377:1995;630-632.
3. Borlongan C.V., Stahl C.E., Cameron D.F., Saporta S., Freeman T.B., Cahill D.W., Sanberg P.R. CNS immunological modulation of neural graft rejection and survival. Neurol. Res. 18:1996;297-304.
4. Borlongan C.V., Cameron D.F., Saporta S., Sanberg P.R. Intracerebral transplantation of testis-derived Sertoli cell promotes functional recovery in female rats with 6-hydroxydopamine-induced hemiparkinsonism. Exp. Neurol. 148:1997;388-392.
5. J.P. Buch, D.J. Tindall, D.R. Rowley, D.J. Lamb, Sertoli cell: structure and function in vivo and in vitro, in: L.I. Lipsultz, S.S. Howard (Eds.), Infertility in the Male, 2nd edn., Mosby-Year Book, St. Louis, 1991, pp. 54-83.
6. Chatelain P.G., Naville D., Saez J.M. Somatomedin-c/insulin-like growth factor I-like material secreted by porcine Sertoli cells in vitro: characterization and regulation. Biochem. Biophy. Res. Commun. 146:1987;1009-1017.
7. Ferrari G., Minozzi M.-C., Toffano G., Leon A., Skaper S.D. Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture. Dev. Biol. 133:1989;140-147.
8. Han I.S., Sylvester S.R., Kim K.H., Schelling M.E., Venkateswaran S., Bkabckaert V.D., Guinness M.P., Griswold M.D. Basic fibroblast growth factor is a testicular germ cell product which may regulate Sertoli cell function. Mol. Endocrinol. 7:1993;889-897.
9. Hitchcock E.H., Whitwell H.L., Sofroniew M.V., Bankiewicz K.S. Survival of TH-positive and neuromelanin-containing cells in patients with Parkinson's disease after intrastriatal grafting of fetal ventral mesencephalon. Exp. Neurol. 129:1994;3.
10. Hudson J.L.C., Van Horne C.G., Stromberg I., Brock S., Clayton J., Masserano J., Hoffer B.J., Gerhardt G.A. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 626:1993;167-174.
11. Kordower J.H., Rosenstein J.M., Collier T.J., Burke M.A., Chen E.-Y., Li J.M., Martel L., Levey A.E., Nufson E.J., Freeman T.B., Olanow C.W. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370:1996;203-230.
12. Lindvall O., Rehncrona S., Brundin P., Gustavii B., Astedt B., Widner H., Lindholm T., Björklund A., Leenders K.L., Rothwell J.C., Frackowiak R., Marsden C.D., Johnels B., Steg G., Freedman R., Hoffer B.J., Seiger A., Bygdeman M., Stromberg I., Olson L. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46:1989;615-631.
13. Mullaney B.P., Skinner M.K. Basic fibroblast growth factor (bFGF) gene expression and protein production during pubertal development of the seminiferous tubule: follicle-stimulating hormone induced Sertoli cell bFGF expression. Endocrinology. 131:1992;2928-2933.
14. Mullaney B.P., Skinner M.K. Transforming growth factor-beta (beta 1, beta 2, and beta 3) gene expression and action during pubertal development of the seminiferous tubule: potential role at the onset of spermatogenesis. Mol. Endocrinol. 7:1993;67-76.
15. Olanow C.W., Kordower J.H., Freeman T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. TINS. 19:1996;102-109.
16. Redmond D.E. Jr., Leranth C., Spencer D.D., Robbins R., Vollmer T., Kim J.H., Roth R.H., Dwork A.J., Naftolin F. Fetal neural graft survival. Lancet. 336:1990;820-822.
17. Sanberg P.R., Borlongan C.V., Saporta S., Cameron D.F. Sertoli cells: an alternative cell source for neural transplantation in Parkinson's disease. Exp. Neurol. 135:1995;169.
18. Sanberg P.R., Borlongan C.V., Saporta S., Cameron D.F. Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nat. Biotechnol. 14:1996;1692-1695.
19. Sanberg P.R., Borlongan C.V., Othberg A.I., Saporta S., Freeman T.B., Cameron D.F. Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats. Nat. Med. 3:1997;1129-1132.
20. Sanberg P.R., Saporta S., Borlongan C.V., Othberg A.I., Allen R.C., Cameron D.F. The testis-derived cultured Sertoli cell as a natural Fas-L secreting cell for immunosuppressive cellular therapy. Cell Transplant. 6:1997;191-193.
21. Saporta S., Cameron D.F., Borlongan C.V., Sanberg P.R. Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression. Exp. Neurol. 146:1997;299-304.
22. Selawry H., Cameron D.F. Sertoli cell-enriched fractions in a successful islet cell transplantation. Cell Transplant. 2:1993;123-129.
23. Skinner M.K., Takacs K., Coffey R.J. Transforming growth factor-α gene expression action in the seminiferous tubule: peritubular cell-Sertoli cell interaction. Endocrinology. 124:1989;845-854.
24. M.K. Skinner, Secretion of growth factors and other regulatory factors, in: L.D. Russell, M.D. Griswold (Eds.), The Sertoli Cell, Cache River Press, FL, 1993, pp. 237-247.
25. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior rats after 6-hydroxy-dopamine lesion of the nigrostriatal dopamine system. Brain Res. 24:1970;485-493.
26. Wu J.C., Gregory C.E., Dephilip R.M. Expression of E-cadherin in immature rat and mouse testis and in rat Sertoli cell cultures. Biol. Reprod. 49:1993;1353-1361.